Unique ID issued by UMIN | UMIN000034145 |
---|---|
Receipt number | R000038894 |
Scientific Title | The effect of compression therapy using surgical gloves on (R-)CHOP therapy induced peripheral neuropathy(randomized control trial) |
Date of disclosure of the study information | 2018/11/01 |
Last modified on | 2024/05/30 15:24:22 |
The effect of compression therapy using surgical gloves on (R-)CHOP therapy induced peripheral neuropathy(randomized control trial)
compression therapy (R-CHOP)
The effect of compression therapy using surgical gloves on (R-)CHOP therapy induced peripheral neuropathy(randomized control trial)
compression therapy (R-CHOP)
Japan |
non-Hodgkin lymphoma
Hematology and clinical oncology |
Malignancy
NO
We study whether compression therapy with surgical gloves is effective for reducing (R-)CHOP induced peripheral neuropathy.
Efficacy
Exploratory
Not applicable
The incidence of (R-)CHOP induced peripheral neuropathy grade 2 or higher between the compression hand and control hand using the CTCAE version 4.0 at one month after treatment
The incidence of (R-)CHOP induced peripheral neuropathy grade 1 or higher between the compression hand and control hand using the CTCAE version 4.0 at following times:before each treatment cycle, and half year after treatment, and one year after treatment
The incidence of (R-)CHOP induced peripheral neuropathy grade B or higher between the compression hand and control hand using the PNQ at following times :before each treatment cycle, and one month after treatment, half year after treatment, and one year after treatment
withdraw from compression therapy
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
NO
1
Prevention
Device,equipment |
For every vincristine infusion, each patients wear two Surgical groves of the same size on their dominant hand for only 100 min: during the 30 min before the administration of vincristine, during the 10 min vincrestine infusion itself, and during the 60 min after the end of the infusion.
18 | years-old | <= |
Not applicable |
Male and Female
patients with untreated malignant lymphoma who receive (R-)CHOP therapy untreated malignant lymphoma
porfomance status 0-2
patients who do not have latex allergy
patients who got written informed consent
patients who treat stem cell transplantation for hematological malignancy
103
1st name | |
Middle name | |
Last name | Suyama Takuya |
Hitachi general hospital
hematology,oncology
2-1-1 Jonan-cho,Hitachi City,Ibaraki prefecture
0294231111
sutaku2468@yahoo.co.jp
1st name | |
Middle name | |
Last name | Suyama Takuya |
Hitachi general hospital
hematology,oncology
2-1-1 Jonan-cho,Hitachi City,Ibaraki prefecture
0294231111
sutaku2468@yahoo.co.jp
Hitachi general hospital
Hitachi general hospital
Self funding
Kanmon medical center
NO
日立総合病院(茨城県),関門医療センター(山口県)
2018 | Year | 11 | Month | 01 | Day |
Published
https://link.springer.com/article/10.1007/s00520-024-08389-3
51
Completed
2018 | Year | 09 | Month | 13 | Day |
2018 | Year | 10 | Month | 16 | Day |
2018 | Year | 11 | Month | 01 | Day |
2024 | Year | 10 | Month | 31 | Day |
2025 | Year | 01 | Month | 30 | Day |
2025 | Year | 03 | Month | 30 | Day |
Intervention study
Patients who recieve (R-)CHOP therapy from novemver 2018 to october 2023.
Items to be measured:age,sex,diagnosis,PS,stage,NCCN-IPI,charlson comobidity index,past histry,treatment effect, survival date,date of death
2018 | Year | 09 | Month | 14 | Day |
2024 | Year | 05 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038894